Biodesix to participate in the canaccord genuity 43rd annual growth conference

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that scott hutton, chief executive officer of biodesix, will present and host in-person 1x1 investor meetings at the canaccord genuity 43rd annual growth conference, which will be held from august 7-10, 2023. canaccord genuity 43rd annual growth conference fireside chat date: wednesday, august 9, 2023 fireside chat time: 4:00 pm et loca.
BDSX Ratings Summary
BDSX Quant Ranking